Home Biosimilar Antibodies Others Others antibody Labetuzumab (Anti-CEACAM5 / CEA / CD66e) For research use only.
Not for use in humans.

Labetuzumab (Anti-CEACAM5 / CEA / CD66e)

Synonyms: null

Labetuzumab (Anti-CEACAM5 / CEA / CD66e) is a humanised monoclonal antibody targeting carcinoembryonic antigen (CEA). It inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy. MW :145.36 KD.

Labetuzumab (Anti-CEACAM5 / CEA / CD66e)

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 6.18mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Labetuzumab (Anti-CEACAM5 / CEA / CD66e) is a humanised monoclonal antibody targeting carcinoembryonic antigen (CEA). It inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy. MW :145.36 KD.

Product Details

CAS No. 219649-07-7
Molecular Weight 145.36
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Labetuzumab (Anti-CEACAM5 / CEA / CD66e) | Labetuzumab (Anti-CEACAM5 / CEA / CD66e) supplier | purchase Labetuzumab (Anti-CEACAM5 / CEA / CD66e) | Labetuzumab (Anti-CEACAM5 / CEA / CD66e) cost | Labetuzumab (Anti-CEACAM5 / CEA / CD66e) manufacturer | order Labetuzumab (Anti-CEACAM5 / CEA / CD66e) | Labetuzumab (Anti-CEACAM5 / CEA / CD66e) distributor